RT: Why @Novartis lost its treatment dispute with @TevaUSA The pharma firm’s arguments failed to convince a London cour… https://t.co/plFtfUvMVD

Azadeh Vahdat explores the recent patent revocation and infringement action between Teva and Novartis over a swallo… https://t.co/RUJtCBOgZV